Data / Drug companies / Granulation Technology, Inc.
Granulation Technology, Inc.: 16 products in the FDA NDC directory, labeler code 63561
Granulation Technology, Inc. (labeler code 63561) lists 16 products in the FDA National Drug Code Directory, covering 8 finished drugs by generic name. By type: 12 prescription drugs, 4 over the counter drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on July 27, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 63561
- Products in commercial distribution
- 16
- Packages
- 35
- Finished drugs by generic name
- 8
- Prescription products
- 12
- Over the counter products
- 4
- Controlled substance products
- Schedule IV 1
- Flagged as original packager
- 16 of 16 products that carry the flag
- Started marketing in the last 12 months
- 6
- Earliest marketing start
- May 22, 2025
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 6 | 37.5% |
| Over the counter monograph drugs | 4 | 25% |
| New drug applications (NDA) | 3 | 18.8% |
| Other unapproved drugs | 3 | 18.8% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 12 | 75% |
| Over the counter drugs | 4 | 25% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Furosemide | 3 | 63 |
| Prednisone | 3 | 49 |
| Hyoscyamine sulfate | 3 | 24 |
| Methocarbamol | 2 | 67 |
| Carisoprodol | 1 | 28 |
| Sennosides, 25 mg | 1 | 1 |
| Docusate sodium, sennosides | 1 | 18 |
| Sennosides, 8.6 mg | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 9 | 56.2% |
| Tablet, film coated | 5 | 31.2% |
| Powder, for solution | 1 | 6.2% |
| Tablet, orally disintegrating | 1 | 6.2% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
| Class | Products |
|---|---|
| Muscle Relaxant | 3 |
| Loop Diuretic | 3 |
| Corticosteroid | 3 |
| Blood Coagulation Factor | 1 |
| Phosphate Binder | 1 |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Hyoscyamine Sulfate | 63561-0203 | Tablet | Other unapproved drugs | July 27, 2026 |
| Hyoscyamine Sulfate | 63561-0197 | Tablet, orally disintegrating | Other unapproved drugs | April 16, 2026 |
| Hyoscyamine Sulfate | 63561-0202 | Tablet | Other unapproved drugs | April 13, 2026 |
| Furosemide | 63561-0166 | Tablet | New drug applications (NDA) | December 18, 2025 |
| Furosemide | 63561-0165 | Tablet | New drug applications (NDA) | December 18, 2025 |
| Furosemide | 63561-0164 | Tablet | New drug applications (NDA) | December 18, 2025 |
| Senna-S | 63561-0187 | Tablet, film coated | Over the counter monograph drugs | July 29, 2025 |
| Astringent | 63561-0178 | Powder, for solution | Over the counter monograph drugs | June 12, 2025 |
| Vegetable Laxative | 63561-0188 | Tablet, film coated | Over the counter monograph drugs | June 11, 2025 |
| Laxative | 63561-0186 | Tablet, film coated | Over the counter monograph drugs | June 11, 2025 |
| Carisoprodol Tablets, USP, 350 mg | 63561-0127 | Tablet | Generic drugs (ANDA) | June 11, 2025 |
| Methocarbamol Tablets, USP, 750 mg | 63561-0174 | Tablet, film coated | Generic drugs (ANDA) | June 10, 2025 |
| Methocarbamol Tablets, USP, 500 mg | 63561-0173 | Tablet, film coated | Generic drugs (ANDA) | June 10, 2025 |
| PredniSONE Tablets, USP, 20 mg | 63561-0122 | Tablet | Generic drugs (ANDA) | May 22, 2025 |
| PredniSONE Tablets, USP, 10 mg | 63561-0121 | Tablet | Generic drugs (ANDA) | May 22, 2025 |
| PredniSONE Tablets, USP, 5 mg | 63561-0120 | Tablet | Generic drugs (ANDA) | May 22, 2025 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.